Min.Order / FOB Price:Get Latest Price
1 Kilogram |
Negotiable |
Ruxolitinib phosphate Ruxolitinib phosphate powder 99% Ruxolitinib phosphate
cas 1092939-17-7 99 % Ruxolitinib phosphate powder
Product Name: | Ruxolitinib phosphate |
CAS: | 1092939-17-7 |
MF: | C17H21N6O4P |
MW: | 404.37 |
what is Ruxolitinib
Ruxolitinib is an oral inhibitor of JAK1 and JAK2, which is approved for the treatment of myeloproliferative neoplasm-associated myelofibrosis, further myeloproliferative neoplasms, polycythemia vera and refractory cancer. In the USA, Canada and EU, ruxolitinib is approved for the treatment of patients with intermediate or high-risk PMF, post-PV MF or post-ET MF. In addition, ruxolitinib recently has been approved for the treatment of patients with PV who have had an inadequate response to or are intolerant of hydroxyurea, based on the results of Phase II and III clinical studies.
Ruxolitinib function
The phosphate salt of Ruxolitinib . Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.
CAS NO:121062-08-6
CAS NO:1224690-84-9
CAS NO:154992-24-2
CAS NO:30123-17-2
CAS NO:30123-17-2
CAS NO:50-28-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View